methoxyhydroxyphenylglycol has been researched along with naltrexone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleber, HD; Kosten, TR; Morgan, C | 1 |
| Attila, LM | 1 |
| Bagne, CA; Deptula, D; Galloway, MP; Pomara, N; Rhiew, HB; Stanley, M; Tamminga, CA; Tanimoto, K; Verebey, K | 1 |
| Charney, DS; Galloway, MP; Heninger, GR; Kleber, HD; Murberg, M; Redmond, DE; Roth, RH | 1 |
| Kelsoe, JR; Konicki, PE; Pato, C; Pickar, D; Rapaport, MH; Wolkowitz, O | 1 |
| Castells, MT; Laorden, ML; Martínez, MD; Martínez, PJ; Milanés, MV | 1 |
| Canpolat, S; Kelestimur, H; Kumru, S; Kutlu, S; Ozcan, M; Sandal, S; Yilmaz, B | 1 |
4 trial(s) available for methoxyhydroxyphenylglycol and naltrexone
| Article | Year |
|---|---|
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1992 |
Loss of the cortisol response to naltrexone in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naltrexone; Prolactin | 1988 |
Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
Topics: Adult; Blood Pressure; Brain; Female; Humans; Kinetics; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Narcotics; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naltrexone; Narcotic Antagonists; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
3 other study(ies) available for methoxyhydroxyphenylglycol and naltrexone
| Article | Year |
|---|---|
Effects of acute morphine administration on noradrenaline turnover and metabolism in various brain parts of control and handled rats.
Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Male; Methoxyhydroxyphenylglycol; Morphine; Naltrexone; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Physiological | 1989 |
Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Suprachiasmatic Nucleus; Supraoptic Nucleus | 2000 |
Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cinnamates; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Methoxyhydroxyphenylglycol; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Oxytocin; Paraventricular Hypothalamic Nucleus; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Supraoptic Nucleus | 2004 |